Article
Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase.
PloS one - 1 Jan 2011
Haagsma Anna C, Podasca Ioana, Koul Anil, Andries Koen, Guillemont Jerome, Lill Holger, Bald Dirk
Abstract excerpt
Infections with Mycobacterium tuberculosis are substantially increasing on a worldwide scale and new antibiotics are urgently needed to combat concomitantly emerging drug-resistant mycobacterial strains. The diarylquinoline TMC207 is a highly promising drug candidate for treatment of tuberculosis. This compound kills M. tuberculosis by binding to a new target, mycobacterial ATP synthase. In this study we used...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
